TransMedics TMDX Stock
TransMedics Price Chart
TransMedics TMDX Financial and Trading Overview
| TransMedics stock price | 69.69 USD |
| Previous Close | 67.2 USD |
| Open | 66.41 USD |
| Bid | 49.71 USD x 200 |
| Ask | 84.03 USD x 200 |
| Day's Range | 65.25 - 69.38 USD |
| 52 Week Range | 60.11 - 156 USD |
| Volume | 1.3M USD |
| Avg. Volume | 1.29M USD |
| Market Cap | 2.33B USD |
| Beta (5Y Monthly) | 2.061 |
| PE Ratio (TTM) | 15.45309 |
| EPS (TTM) | 4.37 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 116.78 USD |
TMDX Valuation Measures
| Enterprise Value | 2.72B USD |
| Trailing P/E | 15.45309 |
| Forward P/E | 19.006151 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.6702862 |
| Price/Book (mrq) | 4.8913517 |
| Enterprise Value/Revenue | 4.284 |
| Enterprise Value/EBITDA | 21.733 |
Trading Information
TransMedics Stock Price History
| Beta (5Y Monthly) | 2.061 |
| 52-Week Change | -45.78% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 156 USD |
| 52 Week Low | 60.11 USD |
| 50-Day Moving Average | 93.47 USD |
| 200-Day Moving Average | 118.41 USD |
TMDX Share Statistics
| Avg. Volume (3 month) | 1.29M USD |
| Avg. Daily Volume (10-Days) | 1.38M USD |
| Shares Outstanding | 34.56M |
| Float | 33.45M |
| Short Ratio | 4.91 |
| % Held by Insiders | 3.39% |
| % Held by Institutions | 108.86% |
| Shares Short | 8.18M |
| Short % of Float | 36.90% |
| Short % of Shares Outstanding | 23.66% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 27.03% |
| Operating Margin (ttm) | 7.64% |
| Gross Margin | 59.08% |
| EBITDA Margin | 19.71% |
Management Effectiveness
| Return on Assets (ttm) | 5.19% |
| Return on Equity (ttm) | 45.22% |
Income Statement
| Revenue (ttm) | 635.89M USD |
| Revenue Per Share (ttm) | 18.62 USD |
| Quarterly Revenue Growth (yoy) | 21.19% |
| Gross Profit (ttm) | 375.74M USD |
| EBITDA | 125.35M USD |
| Net Income Avi to Common (ttm) | 171.92M USD |
| Diluted EPS (ttm) | 4.37 |
| Quarterly Earnings Growth (yoy) | -71.50% |
Balance Sheet
| Total Cash (mrq) | 461.74M USD |
| Total Cash Per Share (mrq) | 13.36 USD |
| Total Debt (mrq) | 863.41M USD |
| Total Debt/Equity (mrq) | 174.78 USD |
| Current Ratio (mrq) | 6.737 |
| Book Value Per Share (mrq) | 13.806 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 220.23M USD |
| Levered Free Cash Flow (ttm) | 108.82M USD |
Profile of TransMedics
| Country | United States |
| State | MA |
| City | Andover |
| Address | 200 Minuteman Road |
| ZIP | 01810 |
| Phone | 978 552 0900 |
| Website | https://www.transmedics.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 898 |
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Q&A For TransMedics Stock
What is a current TMDX stock price?
TransMedics TMDX stock price today per share is 69.69 USD.
How to purchase TransMedics stock?
You can buy TMDX shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TransMedics?
The stock symbol or ticker of TransMedics is TMDX.
Which industry does the TransMedics company belong to?
The TransMedics industry is Medical Devices.
How many shares does TransMedics have in circulation?
The max supply of TransMedics shares is 34.56M.
What is TransMedics Price to Earnings Ratio (PE Ratio)?
TransMedics PE Ratio is 15.94737000 now.
What was TransMedics earnings per share over the trailing 12 months (TTM)?
TransMedics EPS is 4.37 USD over the trailing 12 months.
Which sector does the TransMedics company belong to?
The TransMedics sector is Healthcare.
TransMedics TMDX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Global Market Composite NQGM | 2296 USD — |
-1.38
|
— — | 2280.64 USD — | 2323.09 USD — | — - | — — |
| US Tech US 700 Small Cap Index NQUS700SC | 2992.49 USD — |
-1.38
|
— — | 2986.86 USD — | 3018.97 USD — | — - | — — |
| US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG | 4054.02 USD — |
-0.25
|
— — | 4019.75 USD — | 4077 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}